Literatur
-
1
Szucs T D, Klose G, Düsing B.
Kosteneffektivität von Atorvastatin zur Prävention der koronaren Herzkrankheit. Eine Analyse der ASCOT-Studie.
Dtsch Med Wochenschr.
2004;
129
1420-1424
-
2
Sever P S, Dahlöf B. et al. for the ASCOT investigators .
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average Cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA).
Lancet.
2003;
361
1149-1158
Dr. med. Volker Traut
Am Himmelreich 1
79312 Emmendingen
